Kidney transplantation and too-sick removal among waitlisted candidates with prior malignancy: a retrospective OPTN/UNOS cohort study, 2000– 2026
This retrospective cohort study of nearly one million US kidney transplant candidates found that, among those already waitlisted, a recorded prior malignancy is associated with a modestly higher five-year probability of transplantation—driven by increased living-donor transplants—alongside a higher risk of removal due to being too sick.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For millions of people living with kidney failure, the path to a new life often leads to a waiting list. This list is a registry of patients who are medically ready to receive a donated kidney but must wait for an organ to become available. The process is a race against time, balancing the hope of a transplant against the risks of staying on dialysis, a machine that filters blood when the kidneys cannot. For patients who have survived cancer in the past, this race carries an extra layer of complexity. Doctors must weigh the life-saving potential of a transplant against the fear that powerful medicines used to prevent organ rejection might cause the cancer to return. While guidelines exist to help doctors decide who is safe to list, it has remained unclear how having a history of cancer actually affects a patient's chances of getting a transplant once they are already on the list. Does a past cancer diagnosis slow a patient down, or does it change the path they take to reach a new kidney?
A large team of researchers set out to answer this question by looking at a massive collection of records from the United States. They examined data from nearly one million adult patients who were registered for a kidney transplant between the year 2000 and mid-2026. This dataset, maintained by the national network that manages organ sharing, allowed them to track the journeys of patients with a recorded history of cancer and compare them to those without such a history. The researchers were not looking at who got listed or who was turned away; they focused strictly on what happened to people who were already on the waitlist. They wanted to know if a prior cancer diagnosis changed the likelihood of receiving a kidney within five years, and if it altered the type of kidney received or the reasons a patient might be removed from the list before getting one.
The study revealed a surprising and nuanced picture. Among the more than 920,000 registrations analyzed, about 8 percent included a record of a prior malignancy. When the researchers adjusted for factors like age, race, and other health conditions, they found that patients with a history of cancer were actually slightly more likely to receive a kidney transplant within five years than those without such a history. Specifically, the chance of getting a transplant was about 47 percent for those with prior cancer, compared to roughly 46 percent for those without. While this difference is small, it is statistically significant and suggests that being on the list with a cancer history does not automatically disadvantage a patient in the race for an organ.
However, the story of how these patients received their kidneys tells a more complex tale. The researchers discovered that the higher overall success rate for patients with prior cancer was driven almost entirely by one specific source: living donors. Patients with a history of cancer were significantly more likely to receive a kidney from a living person, such as a family member or friend, than those without a cancer history. In contrast, their chances of receiving a kidney from a deceased donor were slightly lower. This suggests that the path to a transplant for these patients often involves a different route, one that relies more heavily on the generosity of living donors rather than the national pool of organs from deceased donors.
The study also highlighted a sobering reality for this group. While they were slightly more likely to get a transplant, they were also more likely to be removed from the waiting list because they became too sick to undergo the surgery. The researchers found that patients with a history of cancer were removed for this reason at a higher rate than their counterparts without cancer. This outcome does not necessarily mean the cancer itself returned; rather, it indicates that these patients may face a higher burden of other health issues, such as heart disease or general frailty, which can make them too weak to survive the operation. The data shows that the journey for these patients is marked by a distinct pattern: a higher reliance on living donors to secure a transplant, but also a greater risk of becoming too ill to proceed before an organ arrives.
These findings offer a clearer view of the landscape for patients with a history of cancer who are waiting for a kidney. The results indicate that a past cancer diagnosis does not close the door to transplantation, but it does shape the journey. The slight increase in overall success is balanced by a shift toward living donors and a higher risk of being removed due to declining health. For the patients and doctors navigating this difficult path, the data suggests that the focus should remain on individual assessment. The presence of a prior cancer is not a barrier to entry, but it is a factor that changes the odds and the pathways, requiring careful attention to both the opportunity for a living donation and the management of overall health while waiting.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.